Biotech | March 31, 2022
BioVaxys expands cancer vaccine platform
BVX-0922 to target colorectal cancer under investigator-sponsored IND
BVX-0922 to target colorectal cancer under investigator-sponsored IND
Career achievement for contributions in Physiologically based pharmacokinetic (PBPK) and biologically based does response (BBDR) modelling tools
This is the sixth successful USFDA audit for this facility
The SMILE-100 System is a breast thermography device that helps healthcare personnel review, measure and analyze thermally significant indications in the breast region
Amit Jaju, Senior Managing Director, India in an interview with Thomas C Thottathil outlined the steps Indian pharma companies should follow to be compliant with global regulatory requirements
WuXi STA’s drug product site in Wuxi City offers a full range of services including formulation development and manufacturing for a broad range of oral and injectable dosage forms
100% efficacy against severe Covid-19 disease and hospitalizations
Last year, the company's early-stage breast cancer detection test became the first such test to receive the Breakthrough Device Designation
It has a total of 50 ANDA approvals from USFDA
The audit is a PAI for two of its product applications filed from this facility
Subscribe To Our Newsletter & Stay Updated
